JOHNSON KENNETH ERLAND

Insider profile

JOHNSON KENNETH ERLAND's trades of Xeris Pharmaceuticals Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2020-02-18 2020-02-14 B Purchase
86,184 -26.6%
378.74
US$4,207,994
86,184 -26.6% 378.74 US$4,207,994
2019-02-25 2019-02-19 B Purchase
56,710 +48.3%
282.60
US$1,460,245
56,710 +48.3% 282.60 US$1,460,245